SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Phillis Wheatley

PatientPhillis Wheatley
Date of birth2006-07-01
IdentifiersMRN HR-EN015-SYN; SSN (made up) 000-15-3360
Document date2026-02-23
AuthorAbena Hartley-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Diagnosis visit: lung function and FeNO results with the pulmonology consultation. [S]

History of Present Illness

Miss Wheatley returns two weeks after her first visit. This morning she had spirometry before and after albuterol and FeNO in the pulmonary function laboratory, and she then saw Dr. Fairbanks-Mensah. Her symptoms are unchanged in the cold weather: wheeze and cough on three or four days a week, waking with a tight chest about twice a month, and breathlessness climbing hills in the wind. The tuberculosis blood test and urine pregnancy test from the first visit were negative. She wants to understand exactly what the tests show and asks whether she will be well enough to travel by sea later in the spring. She came alone and was seen alone. [S]

ElementDetail
Tests this morningSpirometry with bronchodilator response, and FeNO
Results from the first visitInterferon-gamma release assay negative; urine pregnancy test negative; chest X-ray clear; blood eosinophils 0.38
Her questionIs it asthma, and can she travel by sea in the spring?

Review of Systems

SystemResultFinding
RespiratoryPositiveWheeze and cough three or four days a week; night waking about twice a month; breathless on hills in cold air
ConstitutionalNegativeNo fever, night sweats or weight loss; weight 45.8 kg
Ears, nose, mouth, and throatNegativeNo nasal blockage or hoarseness
PsychiatricNegativeCalm; keen to understand her results

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a dayOne inhalation as neededRespiratory tract route2026-02-23 to 2026-09-21completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-02-23Body height152cmS
2026-02-23Body weight45.8kgS
2026-02-23Body mass index (BMI) [Ratio]19.8kg/m2S
2026-02-23Systolic blood pressure106mm[Hg]S
2026-02-23Diastolic blood pressure66mm[Hg]S
2026-02-23Heart rate82/minS
2026-02-23Respiratory rate16/minS
2026-02-23Body temperature36.6CelS
2026-02-23Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-23FEV1 --pre bronchodilation2.24LLower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations)NormalS
2026-02-23FEV1 --post bronchodilation2.57LLower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations)NormalS
2026-02-23FEV1 measured/predicted83%GLI Global race-neutral equationsNormalS
2026-02-23FEV1/FVC0.72{ratio}Lower limit of normal for her age (GLI Global)LowS
2026-02-23FEV1/FVC --post bronchodilation0.8{ratio}Lower limit of normal for her age (GLI Global)NormalS
2026-02-23Fractional concentration of exhaled nitric oxide38[ppb]Above 50 ppb high; 25 to 50 intermediate (ATS)HighS
2026-02-23IgE [Units/volume] in Serum or Plasma165[IU]/mL<=100 [IU]/mLHighS
2026-02-23Total score [ACT]16{score}S

Physical Exam

Vital signs recorded on 2026-02-23; see the Vital Signs section. [S]

SystemFinding
GeneralSlight, composed and attentive; speaks in full sentences; weight 45.8 kg; oxygen saturation 98 percent
RespiratoryFaint expiratory wheeze on forced expiration; no crackles
CardiovascularRegular rhythm; no murmur

Problems

ProblemClinical statusVerificationCodeProvenance
Wheeze, cough and breathlessness this winter, for about three months: symptoms on three or four days a week, waking with cough and a tight chest about twice a month, breathless climbing the hill streets in cold air; worse with cold wind, kitchen and fireplace smoke, and colds; called a weak chest and asthma since childhood but never tested or treated. Asthma to be confirmed with spirometry before and after bronchodilator and FeNOresolvedconfirmed R06.2S — Synthetic presenting problem anchored to her documented frail, asthmatic childhood. Superseded by the diagnosis at the second visit.
Asthma, confirmed, mild persistent: variable airflow obstruction (FEV1/FVC 0.72, below the lower limit of normal, rising to 0.80 after bronchodilator; FEV1 2.24 L, 83 percent predicted, rising 330 mL or 15 percent); type 2 inflammation (FeNO 38 ppb, blood eosinophils 0.38 x10^3/uL, total IgE 165, house dust mite sensitization); tuberculosis infection test negative and chest X-ray clear. Triggers: cold air, kitchen and fireplace smoke, coldsactiveconfirmed J45.30S — Synthetic modern confirmation linked to her documented frail, asthmatic childhood and her own later descriptions of asthma.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ImagingSpirometry with bronchodilator response, read with race-neutral equationsAt diagnosis, before starting controller therapyCompleted todayFEV1 2.24 L (83 percent) to 2.57 L (+330 mL, +15 percent); FEV1/FVC 0.72 to 0.80
ImagingFeNOWhen the diagnosis is uncertain, and to monitor response (NAEPP, conditional)Completed today38 ppb, intermediate
LaboratoryBlood eosinophils and total and specific IgE (phenotyping)At diagnosisCompleted todayEosinophils 0.38 two weeks ago; total IgE 165; house dust mite specific IgE positive; cat and mold negative
LaboratoryExclusion of tuberculosis and other chest diseaseAt diagnosis, for a person born where tuberculosis is commonUp to dateInterferon-gamma release assay negative and chest X-ray clear at the first visit
SurveyAsthma Control Test, symptoms, night waking and reliever useEvery visitCompleted todayAsthma Control Test 16; symptoms three or four days a week; night waking twice a month
ExaminationInhaler technique with her own inhaler, and adherenceEvery visit; before any step-upCompleted todayTaught today with her new inhaler and a spacer; demonstrated correctly
Self-managementWritten asthma action planEvery visit and after every exacerbationCompleted todayWritten plan with peak flow zones given
Self-managementExacerbation history (oral corticosteroid courses, emergency visits, admissions)Every visitCompleted todayNo oral corticosteroid course, emergency visit or admission ever
Self-managementStep-up or step-down assessment (GINA track 1)Every visitCompleted todayStarting at step 2: as-needed low-dose budesonide-formoterol
Self-managementTriggers, exposures and smoking or vapingEvery visitCompleted todayNever smoked or vaped; cold air, cooking and fireplace smoke, colds; house dust mite sensitization
ExaminationComorbidities: rhinitis, reflux, mood, anxietyAt diagnosis and yearlyCompleted todayNo rhinitis or reflux symptoms; PHQ-2 1 at the first visit
Self-managementVaccinationsYearlyCompleted todayInfluenza, COVID-19 and PCV20 today
ReferralBiologic assessmentWhen asthma is severe or uncontrolled despite optimized step 4 to 5 treatmentNot indicatedMild asthma; treatment has only now started
Self-managementEquity: race-neutral interpretation and plain explanationEvery testCompleted todayRead with GLI Global equations; results explained to her in plain words, with a printed copy for her
Self-managementPrivate conversation: consent, safety and exploitation, and her own decisionsEvery visitCompleted todaySeen alone; she consented to each test and treatment; results kept to her own contact details

Goal progress:

Immunizations given today: Influenza vaccine, this season; COVID-19 mRNA vaccine, this season's formula; Pneumococcal conjugate vaccine PCV20 [S]

Guideline basis: CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); Bhakta NR, et al. Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement. Am J Respir Crit Care Med 2023;207(8):978-995 (PMID 36973004) (2023); Adult Immunization Schedule by Medical Condition and Other Indication (2026)

Follow-up: Six-week review. Follow the action plan: more reliever inhalations and a call to the clinic in the yellow zone; emergency care in the red zone. Next scheduled visit 2026-04-06: six-week asthma review: control, technique, personal best peak flow, triggers, and planning for a long sea journey and a summer away. [S]